Director Matthew K Fust sold $455K of Ultragenyx Pharmaceutical Inc.

Sold$454,969

$72.00Price

6,319Shares

−42%Stake

What RARE did after the filing

Prices for RARE after this filing aren't in yet.

Traded Wed, May 30. Filed Wed, May 30, 3:26 PM ET, during the session. Not investment advice.